Avalo Therapeutics (AVTX) EPS (Basic) (2014 - 2026)
Avalo Therapeutics' (AVTX) quarterly EPS (Basic) came in at -$0.98 in Q1 2026, up 21.93% YoY from -$0.8 in Q1 2025, and up 4.61% on a QoQ basis from -$1.02 in Q4 2025.
Powered by 
Analysis
Avalo Therapeutics (AVTX) EPS (Basic) (2014 - 2026) Analysis & Trends
Avalo Therapeutics (AVTX) has 12 years of EPS (Basic) data on file, last reported at -$0.98 in Q1 2026.
- Quarterly EPS (Basic) rose 21.93% year-over-year to -$0.98 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.21 (down 160.7% YoY) and the FY2025 annual result came in at -$5.84, up 26.44% from the prior year.
- EPS (Basic) grew to -$0.98 in Q1 2026, from -$1.02 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $95.21 in Q2 2024 to a low of -$203.65 in Q1 2023.
- A 4-year average of -$35.2 and a median of -$2.19 in 2025 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) surged 167.71% — and 2025, when it tumbled 152.66%.
- Tracing AVTX's EPS (Basic) over 4 years: stood at -$29.41 in 2023, then soared by 72.85% to -$7.98 in 2024, then surged by 87.18% to -$1.02 in 2025, then rose by 4.61% to -$0.98 in 2026.
- The last three EPS (Basic) figures came in at -$0.98 (Q1 2026), -$1.02 (Q4 2025), and -$2.19 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Avalo Therapeutics | 838.25 Mn | 838.25 Mn | - | -0.83 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.83 |
| Mar 31, 2026 | -1.46 |
| Dec 31, 2025 | -1.02 |
| Sep 30, 2025 | -2.19 |
| Jun 30, 2025 | -1.92 |
| Mar 31, 2025 | -1.25 |
| Dec 31, 2024 | -7.98 |
| Sep 30, 2024 | 4.15 |
| Jun 30, 2024 | 95.21 |
| Mar 31, 2024 | -141.14 |
| Dec 31, 2023 | -29.41 |
| Sep 30, 2023 | -26.81 |
| Jun 30, 2023 | -140.62 |
| Mar 31, 2023 | -203.65 |
| Dec 31, 2022 | -250.10 |
| Sep 30, 2022 | 81.32 |
| Jun 30, 2022 | -331.28 |
| Mar 31, 2022 | -562.58 |
| Dec 31, 2021 | -553.60 |
| Sep 30, 2021 | -498.14 |